contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  createdAt
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
    forum {
      threadUrl
    }
    defaultInstrument {
      symbol
      id
    }
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  createdAt
  changedAt
  isPremium
  authors {
    __typename
    name
    pageUrl
    id
  }
  companies {
    name
    pageUrl
    id
  }
  tags {
    name
    id
  }
  ... on Video {
    liveTime
    videoUrl
    videoEmbedUrl(location: "inderes")
  }
  ... on Webcast {
    liveTime
    videoUrl
    videoEmbedUrl(location: "inderes")
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        threadUrl
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        symbol
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
      researchContentUrl
      researchContent {
        title
        lang
        pdfUrl
        relatedContent {
          __typename
          ...PublishingDetails
          ...Reactions
          id
        }
        content {
          title
          lang
          htmlBody
          publishedAt
          createdAt
          changedAt
          isOutdated
          isPremium
        }
      }
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


sectra-publicerar-arsredovisning-och-hallbarhetsrapport-for-20252026

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

changedAt

Sectra operates in the medical technology industry and focuses on the development and manufacture of systems for imaging diagnostics and secure communication. The company's products are aimed at healthcare institutions and doctors. The business is conducted internationally, where the company sells through collaboration with partners all over the world. Sectra was founded in 1957 and is headquartered in Linköping.

Sorry @JNivala, for replying with such a three-year delay. I just got caught up reading about this company.  Sectra does two things: Medical IT – They develop systems that help hospitals and healthcare manage imaging + data more effectively. In practice, they help doctors do their work more efficiently and treat patients better. These are important things as the population ages and the need for care grows. Cybersecurity – Sectra also does information security stuff, especially for the defense sector, healthcare, and other critical sectors. Because everything is becoming more digital, it’s essential to protect against data breaches and cyberattacks… that’s what they do. So their solutions help keep important systems secure. In short:  Sectra earns money by selling healthcare IT solutions and cybersecurity services. The revenue stream consists of software, hardware, service agreements, and ongoing license fees – these are provided especially to hospitals, defense forces, and critical infrastructure operators who need secure and efficient systems.

@Maunotellervon_poika, could you briefly answer a couple of things so I know if it’s worth digging into more:  What are the business areas? What is the business model, where does the money come from? P/E according to Nordnet with this year’s forecast figures is 125, and P/S is 25. Any thoughts on these? Management’s holdings?

The Dutch Ministry of Defense continues cooperation with Sectra:                   Investor Relations at Sectra              News and press releases | Investor Relations at Sectra    Linköping – November 30, 2021 – The Dutch Ministry of Defense has signed a new framework agreement with international cybersecurity and medical imaging IT company Sectra (https://sectra.com/) (STO: SECT B). The 5-year contract contains the approved...

Sectra AB was added to the MSCI Global Small Cap Index on November 11, 2021 (page 8 of the announcement). On the same day, the share price rose by about 9%.            app2.msci.com              MSCI_Nov21_SCPublicList.pdf    31.76 KB

Norway orders Sectra Tiger solution for sharing classified information Nov 17, 2021 | Secure Communication Systems | Norway Linköping – November 17, 2021 – The Norwegian Defence Materiel Agency has ordered additional units of the approved mobile encryption system Sectra Tiger/S from international cybersecurity and medical imaging IT company Sectra (STO: SECT B). The solution enables officials in the Norwegian defense and civil authorities to communicate securely and efficiently, preventing the risk of eavesdropping or information leakage. The new order encompasses the latest version of Sectra Tiger/S, which also guarantees the user higher availability from anywhere and at any time.                   Investor Relations at Sectra              News and press releases | Investor Relations at Sectra    Linköping – November 17, 2021 – The Norwegian Defence Materiel Agency has ordered additional units of the approved mobile encryption system Sectra Tiger/S from international cybersecurity and medical imaging IT company...

Investor Relations at Sectra              News and press releases | Investor Relations at Sectra    Linköping, Sweden and Shelton, CT – October 28, 2021 – “Brilliant workflows. Made for you.” is the key theme for international medical imaging IT and cybersecurity...

Hello, I decided to start my own thread for Sectra AB. I’ve commented on the company a few times in the cybersecurity forum, but I primarily see this as a top expert in medical imaging, and since the company seems to be doing well, I would appreciate comments and analyses on Sectra’s status and future from forum members smarter than myself. I’ve been secretly invested in Sectra for several years. Initially, through Nordea’s Selecta insurance fund, which turned out to be completely absurd , into which I saved at the turn of the millennium and which was somewhat forcibly sold to me at the bank counter (back when people still did business in branches ). This mistake, however, had the benefit that I thus became more closely acquainted with the companies contained within the fund, including this Sectra . It repeatedly appeared in the fund’s annual reports with an ever-increasing share, and later it was even specifically praised in the fund prospectus. I bought independent shares for the first time two or three years ago and have topped up a few times, most recently during this spring’s dip, from which the price has almost doubled. I haven’t regretted it. When the price approached 1000 SEK this year, it was recently split 5:1. Sectra was founded in 1978 and listed on Nasdaq Stockholm in 2014. I don’t know exactly when the fund was included in Nordea’s Nordic Small Cap fund, which I am obliged to own until retirement. For the past five years, the price has mostly been on an upward trend, and today the company’s market value was already 39,373.05 MSEK.                    Investor Relations at Sectra              Sectra in brief | Investor Relations at Sectra    Sectra operates in the expanding niche segments of medical IT and cybersecurity. Driven by knowledge and passion, our vision is to contribute to a...         Est. reading time: 1 minute                               I also found something in Finnish, a relatively recent presentation of the company, where Nordea Innovation Stars’ Portfolio Manager Carl Mattiasson also presents his views on Sectra (and tries to sell that particular fund, so one must read that fact with a critical eye). https://nordeafundsmagazine.fi/artikkelit/sectra I am a somewhat intuitive investor and don’t always research and turn over every stone. Perhaps one of you can help me with this? What do you think, and does anyone else have this company in their portfolio? (Owners in Nordnet: 1,803 – are all the others Swedish, or is there another Finnish owner besides me?) I also added this: A link to the most recent video from the interim report.                   Investor Relations at Sectra              Three-month interim report 2021/2022 | Investor Relations at Sectra    Sectra’s Executive Management will present the financial report and respond to any questions.

Sectra

Linköping - 8 juli 2026 - Det internationella medicinteknik- och cybersäkerhetsföretaget Sectra (STO: SECT B) publicerar i dag årsredovisning och hållbarhetsrapport för verksamhetsåret 2025/...

<div class="abstract">Linköping - 8 juli 2026 - Det internationella medicinteknik- och cybersäkerhetsföretaget <a href="https://sectra.com/">Sectra</a> (STO: SECT B) publicerar i dag årsredovisning och hållbarhetsrapport för verksamhetsåret 2025/2026. Denna innehåller också styrelsens bolagsstyrningsrapport för samma period.</div>Dokumenten är bifogade till detta pressmeddelande och finns även tillgängliga på Sectras webbplats, <a href="https://investor.sectra.com">investor.sectra.com</a>.&nbsp;På webbplatsen ges också en sammanfattning av verksamhetsåret. I <a href="https://investor.sectra.com/year2526overview">The 2025/2026 financial year in brief</a> (språk engelska) summeras höjdpunkter från våra verksamheter och ett urval av finansiella nyckeltal.&nbsp;Denna information är sådan information som Sectra AB (publ) är skyldigt att offentliggöra enligt lagen om värdepappersmarknaden. Informationen lämnades, genom nedanstående kontaktpersons försorg, för offentliggörande den 8 juli, 2026, kl. 10.45.<div></div>

Sectra publicerar årsredovisning och hållbarhetsrapport för 2025/2026

Sectra publicerar årsredovisning och hållbarhetsrapport för 2025/2026